Medical University of Vienna

🇦🇹Austria

Country: 🇦🇹Austria

Ownership: Private

Established: 1365-01-01

Employees: 1K

Market Cap: -

Website: http://www.meduniwien.ac.at

Clinical Trials

Women With Asymptomatic Endometrial Hyperplasia

Completed

Conditions: Endometrial Hyperplasia

Interventions: Other: vaginal ultrasound

First Posted Date: 2014-03-31

Last Posted Date: 2014-03-31

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 1000

Registration Number: NCT02100137

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds

Not Applicable

Completed

Conditions: Chronic Diabetic Foot Ulcers

Interventions: Device: PrimeStim

First Posted Date: 2014-03-28

Last Posted Date: 2017-03-31

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 24

Registration Number: NCT02098447

Locations: 🇦🇹
University Clinic for Surgery, Department of Transplantation, Medical University Vienna, Vienna, Austria

IPHAAB-study Influence of Physical Activity on Atherosclerosis Biomarkers

Completed

Conditions: Influence of 8 Months of Increased Physical Activity Workload on Osteoprotegerin and Endocan Levels

Interventions: Other: Increased sports workload

First Posted Date: 2014-03-26

Last Posted Date: 2016-01-07

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 98

Registration Number: NCT02097199

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Teriparatide for Fracture Repair in Humans

Phase 3

Withdrawn

Conditions: Humeral Fractures
Osteoporosis, Age-Related

Interventions: Drug: Placebo
Drug: Teriparatide

First Posted Date: 2014-03-19

Last Posted Date: 2015-09-17

Lead Sponsor: Medical University of Vienna

Registration Number: NCT02091492

Locations: 🇦🇹
Medical University Vienna; St. Vincent Hospital, Vienna, Austria

Triple vs. Dual Therapy

Phase 1

Completed

Conditions: Atrial Fibrillation
Acute Coronary Syndrome

Interventions: Drug: Ticagrelor + Apixaban + ASA
Drug: Ticagrelor + Apixaban

First Posted Date: 2014-03-06

Last Posted Date: 2015-04-07

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 40

Registration Number: NCT02080858

Locations: 🇦🇹
Medical University of Vienna, Department of Clinical Pharmacology, Vienna, Austria

Intramedullary Devices for the Treatment of Unstable Pertrochanteric Fractures

Not Applicable

Completed

Conditions: Fractures

Interventions: Device: Gamma Nail 3
Device: PFNA

First Posted Date: 2014-03-03

Last Posted Date: 2014-03-03

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 200

Registration Number: NCT02074969

Locations: 🇦🇹
Department of Trauma, Medical University of Vienna, Vienna, Austria

Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma and Their Premalignant Changes.

Not Applicable

Completed

Conditions: Ovarian Epithelial Cancer

Interventions: Procedure: Lavage of the Cavum uteri and proximal fallopian tubes
Procedure: Liquid-PAP smear

First Posted Date: 2014-02-14

Last Posted Date: 2020-02-25

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 50

Registration Number: NCT02062697

Locations: 🇧🇪
University Hospitals Leuven - Department of Obstetrics and Gynaecology, Leuven, Belgium
🇦🇹
Medical University Vienna, Dptm. of Obstetrics & Gynaecology, Vienna, Austria
🇨🇿
Charles University, Pilsen - Medical Faculty Hospital, Department of Obstetrics and Gynecology, Pilsen, Plzeň Region, Czechia

and more 3 locations

Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease

Phase 3

Conditions: Polycystic Kidney, Type 2 Autosomal Dominant Disease
Polycystic Kidney, Type 1 Autosomal Dominant Disease

Interventions: Drug: Placebo
Drug: Sirolimus

First Posted Date: 2014-02-04

Last Posted Date: 2018-10-31

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 68

Registration Number: NCT02055079

Locations: 🇦🇹
Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria

Hemodynamic Effects of Stored Blood Transfusion in Intensive Care Patients

Phase 4

Terminated

Conditions: Pulmonary Hypertension

Interventions: Biological: Blood transfusion

First Posted Date: 2014-01-30

Last Posted Date: 2016-10-27

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 11

Registration Number: NCT02050230

Locations: 🇦🇹
General Hospital of the Medical University of Vienna, Vienna, Austria

Comparison of POC-test-equipment With the Laboratory

Phase 4

Conditions: INR-POC-testing

Interventions: Device: INRatio2 and CoaguChek

First Posted Date: 2014-01-22

Last Posted Date: 2014-01-22

Lead Sponsor: Medical University of Vienna

Registration Number: NCT02042417

Locations: 🇦🇹
MUVienna, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy